Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Molecular typing and in vitro resistance of Cryptococcus neoformans clinical isolates obtained in Germany between 2011 and 2017.

Selb R, Fuchs V, Graf B, Hamprecht A, Hogardt M, Sedlacek L, Schwarz R, Idelevich EA, Becker SL, Held J, Küpper-Tetzel CP, McCormick-Smith I, Heckmann D, Gerkrath J, Han CO, Wilmes D, Rickerts V.

Int J Med Microbiol. 2019 Sep;309(6):151336. doi: 10.1016/j.ijmm.2019.151336. Epub 2019 Aug 16.

PMID:
31444102
2.

Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo.

Göttig S, Frank D, Mungo E, Nolte A, Hogardt M, Besier S, Wichelhaus TA.

J Antimicrob Chemother. 2019 Nov 1;74(11):3211-3216. doi: 10.1093/jac/dkz330.

PMID:
31365094
3.

Quinolone- and multidrug-resistance predict failure of antibiotic prophylaxis of spontaneous bacterial peritonitis.

Mücke MM, Mayer A, Kessel J, Mücke VT, Bon D, Schwarzkopf K, Rüschenbaum S, Queck A, Göttig S, Vermehren A, Weiler N, Welker MW, Reinheimer C, Hogardt M, Vermehren J, Herrmann E, Kempf VAJ, Zeuzem S, Lange CM.

Clin Infect Dis. 2019 Jun 20. pii: ciz540. doi: 10.1093/cid/ciz540. [Epub ahead of print]

PMID:
31228250
4.

Species distribution and clinical features of infection and colonisation with non-tuberculous mycobacteria in a tertiary care centre, central Germany, 2006-2016.

Wetzstein N, Hügel C, Wichelhaus TA, Hogardt M, Eickmeier O, Küpper-Tetzel CP, Kann G, Just-Nübling G, Stephan C, Wolf T.

Infection. 2019 Oct;47(5):817-825. doi: 10.1007/s15010-019-01317-2. Epub 2019 May 15.

PMID:
31093923
5.

Clinical characteristics in a sentinel case as well as in a cluster of tularemia patients associated with grape harvest.

Wetzstein N, Kärcher I, Küpper-Tetzel CP, Kann G, Hogardt M, Jozsa K, Jacob D, Grunow R, Just-Nübling G, Wolf T.

Int J Infect Dis. 2019 Jul;84:116-120. doi: 10.1016/j.ijid.2019.04.031. Epub 2019 May 6.

6.

Tolerizing CTL by Sustained Hepatic PD-L1 Expression Provides a New Therapy Approach in Mouse Sepsis.

von Knethen A, Schäfer A, Kuchler L, Knape T, Christen U, Hintermann E, Fißlthaler B, Schröder K, Brandes RP, Genz B, Abshagen K, Pützer BM, Sha LK, Weigert A, Syed SN, Schulz M, Shah AM, Ernst A, Putyrski M, Finkelmeier F, Pesic M, Greten F, Hogardt M, Kempf VAJ, Gunne S, Parnham MJ, Brüne B.

Theranostics. 2019 Mar 16;9(7):2003-2016. doi: 10.7150/thno.28057. eCollection 2019.

7.

Colonization with multidrug resistant organisms determines the clinical course of patients with acute myeloid leukemia undergoing intensive induction chemotherapy.

Ballo O, Tarazzit I, Stratmann J, Reinheimer C, Hogardt M, Wichelhaus TA, Kempf V, Serve H, Finkelmeier F, Brandts C.

PLoS One. 2019 Jan 23;14(1):e0210991. doi: 10.1371/journal.pone.0210991. eCollection 2019.

8.

Bloodstream infections with vancomycin-resistant enterococci are associated with a decreased survival in patients with hematological diseases.

Weber S, Hogardt M, Reinheimer C, Wichelhaus TA, Kempf VAJ, Kessel J, Wolf S, Serve H, Steffen B, Scheich S.

Ann Hematol. 2019 Mar;98(3):763-773. doi: 10.1007/s00277-019-03607-z. Epub 2019 Jan 21.

PMID:
30666433
9.

Noninvasive screening identifies patients at risk for spontaneous bacterial peritonitis caused by multidrug-resistant organisms.

Ferstl PG, Müller M, Filmann N, Hogardt M, Kempf VA, Wichelhaus TA, Lange CM, Vermehren J, Zeuzem S, Reinheimer C, Waidmann O.

Infect Drug Resist. 2018 Nov 2;11:2047-2061. doi: 10.2147/IDR.S172587. eCollection 2018.

10.

Timepoints of vancomycin-resistant Enterococcus colonization predict outcomes of acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplantation.

Scheich S, Weber S, König R, Wilke AC, Lindner S, Reinheimer C, Wichelhaus TA, Hogardt M, A J Kempf V, Kessel J, Martin H, Bug G, Serve H, Steffen B.

Eur J Haematol. 2018 Jul 26. doi: 10.1111/ejh.13151. [Epub ahead of print]

PMID:
30048011
11.

Stenotrophomonas maltophilia colonization during allogeneic hematopoietic stem cell transplantation is associated with impaired survival.

Scheich S, Koenig R, Wilke AC, Lindner S, Reinheimer C, Wichelhaus TA, Hogardt M, Kempf VAJ, Kessel J, Weber S, Martin H, Bug G, Serve H, Steffen B.

PLoS One. 2018 Jul 19;13(7):e0201169. doi: 10.1371/journal.pone.0201169. eCollection 2018.

12.

Bloodstream infections with gram-negative organisms and the impact of multidrug resistance in patients with hematological malignancies.

Scheich S, Weber S, Reinheimer C, Wichelhaus TA, Hogardt M, Kempf VAJ, Kessel J, Serve H, Steffen B.

Ann Hematol. 2018 Nov;97(11):2225-2234. doi: 10.1007/s00277-018-3423-5. Epub 2018 Jul 4.

PMID:
29974230
13.

[CF Lung Disease - a German S3 Guideline: Module 2: Diagnostics and Treatment in Chronic Infection with Pseudomonas aeruginosa].

Schwarz C, Schulte-Hubbert B, Bend J, Abele-Horn M, Baumann I, Bremer W, Brunsmann F, Dieninghoff D, Eickmeier O, Ellemunter H, Fischer R, Grosse-Onnebrink J, Hammermann J, Hebestreit H, Hogardt M, Hügel C, Hug M, Illing S, Jung A, Kahl B, Koitschev A, Mahlberg R, Mainz JG, Mattner F, Mehl A, Möller A, Muche-Borowski C, Nüßlein T, Puderbach M, Renner S, Rietschel E, Ringshausen FC, Schmidt S, Sedlacek L, Sitter H, Smaczny C, Tümmler B, Vonberg R, Wielpütz MO, Wilkens H, Wollschläger B, Zerlik J, Düesberg U, van Koningsbruggen-Rietschel S.

Pneumologie. 2018 May;72(5):347-392. doi: 10.1055/s-0044-100191. Epub 2018 May 14. German.

PMID:
29758578
14.

Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany.

Seufert R, Sedlacek L, Kahl B, Hogardt M, Hamprecht A, Haase G, Gunzer F, Haas A, Grauling-Halama S, MacKenzie CR, Essig A, Stehling F, Sutharsan S, Dittmer S, Killengray D, Schmidt D, Eskandarian N, Steinmann E, Buer J, Hagen F, Meis JF, Rath PM, Steinmann J.

J Antimicrob Chemother. 2018 Aug 1;73(8):2047-2053. doi: 10.1093/jac/dky147.

PMID:
29684150
15.

[Piperacillin/Tazobactam Shortage: Central Restriction and Alternative Recommendations as Effective Antibiotic-Stewardship Intervention at a Maximal Care Hospital].

Kessel J, Dolff B, Wichelhaus T, Keiner N, Hogardt M, Reinheimer C, Wieters I, Harder S, Kempf VAJ, Stephan C; für das Antibiotic-Stewardship-Team (UKF).

Dtsch Med Wochenschr. 2018 Apr;143(8):e59-e67. doi: 10.1055/s-0043-122706. Epub 2017 Dec 13. German.

PMID:
29237206
16.

Clinical impact of colonization with multidrug-resistant organisms on outcome after allogeneic stem cell transplantation in patients with acute myeloid leukemia.

Scheich S, Lindner S, Koenig R, Reinheimer C, Wichelhaus TA, Hogardt M, Besier S, Kempf VAJ, Kessel J, Martin H, Wilke AC, Serve H, Bug G, Steffen B.

Cancer. 2018 Jan 15;124(2):286-296. doi: 10.1002/cncr.31045. Epub 2017 Sep 28.

17.

The role of Enterococcus spp. and multidrug-resistant bacteria causing pyogenic liver abscesses.

Mücke MM, Kessel J, Mücke VT, Schwarzkopf K, Hogardt M, Stephan C, Zeuzem S, Kempf VAJ, Lange CM.

BMC Infect Dis. 2017 Jun 26;17(1):450. doi: 10.1186/s12879-017-2543-1.

18.

Clinical Impact of Colonization with Multidrug-Resistant Organisms on Outcome after Autologous Stem Cell Transplantation: A Retrospective Single-Center Study.

Scheich S, Reinheimer C, Brandt C, Wichelhaus TA, Hogardt M, Kempf VAJ, Brunnberg U, Brandts C, Ballo O, von Metzler I, Kessel J, Serve H, Steffen B.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1455-1462. doi: 10.1016/j.bbmt.2017.05.016. Epub 2017 May 18.

19.

The impact of carbapenem resistance on clinical deterioration and mortality in patients with liver disease.

Ferstl PG, Filmann N, Brandt C, Zeuzem S, Hogardt M, Kempf VAJ, Müller M, Waidmann O, Reinheimer C.

Liver Int. 2017 Oct;37(10):1488-1496. doi: 10.1111/liv.13438. Epub 2017 May 20.

PMID:
28374901
20.

Draft Genome Sequences of Pandrug-Resistant Serratia marcescens Clinical Isolates Harboring blaNDM-1.

Yao Y, Falgenhauer L, Kempf VA, Hogardt M, Göttig S, Imirzalioglu C, Chakraborty T.

Genome Announc. 2017 Jan 19;5(3). pii: e01481-16. doi: 10.1128/genomeA.01481-16.

21.

Prevalence of multidrug-resistant organisms in refugee patients, medical tourists and domestic patients admitted to a German university hospital.

Reinheimer C, Kempf VA, Jozsa K, Wichelhaus TA, Hogardt M, O'Rourke F, Brandt C.

BMC Infect Dis. 2017 Jan 5;17(1):17. doi: 10.1186/s12879-016-2105-y.

22.

Group B streptococcus infections in neonates admitted to a German NICU: Emphasis on screening and adherence to pre-analytical recommendations.

Reinheimer C, Kempf VA, Wittekindt BE, Allendorf A, Wichelhaus TA, Hogardt M, Schlößer RL, Fischer D.

Early Hum Dev. 2016 Dec;103:37-41. doi: 10.1016/j.earlhumdev.2016.07.007. Epub 2016 Jul 29.

PMID:
27479521
23.

Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.

Preece CL, Wichelhaus TA, Perry A, Jones AL, Cummings SP, Perry JD, Hogardt M.

J Clin Microbiol. 2016 Jul;54(7):1797-1803. doi: 10.1128/JCM.00471-16. Epub 2016 Apr 20.

24.

Author's reply: Is there a need for special treatment of refugees at hospital admission?

Kempf VA, Heudorf U, C Reinheimer, Göttig S, Hogardt M, Wichelhaus TA, O'Rourke F, Brandt C, Krackhardt B, Karathana M, Kleinkauf N, Zinn C.

Euro Surveill. 2016;21(7):pii=30138. doi: 10.2807/1560-7917.ES.2016.21.7.30138. No abstract available.

25.

Microbial colonization and lung function in adolescents with cystic fibrosis.

Hector A, Kirn T, Ralhan A, Graepler-Mainka U, Berenbrinker S, Riethmueller J, Hogardt M, Wagner M, Pfleger A, Autenrieth I, Kappler M, Griese M, Eber E, Martus P, Hartl D.

J Cyst Fibros. 2016 May;15(3):340-9. doi: 10.1016/j.jcf.2016.01.004. Epub 2016 Feb 5.

26.

Multidrug-resistant organisms detected in refugee patients admitted to a University Hospital, Germany June‒December 2015.

Reinheimer C, Kempf VA, Göttig S, Hogardt M, Wichelhaus TA, O'Rourke F, Brandt C.

Euro Surveill. 2016;21(2). doi: 10.2807/1560-7917.ES.2016.21.2.30110.

27.

[Multidrug-resistant organisms (MDRO) in patients in outpatient care in the Rhine-Main region, Germany, in 2014: Prevalence and risk factors].

Neumann N, Mischler D, Cuny C, Hogardt M, Kempf VA, Heudorf U.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Feb;59(2):292-300. doi: 10.1007/s00103-015-2290-7. German.

PMID:
26631014
28.

Cryptococcosis due to Cryptococcus gattii in Germany from 2004-2013.

Smith IM, Stephan C, Hogardt M, Klawe C, Tintelnot K, Rickerts V.

Int J Med Microbiol. 2015 Oct;305(7):719-23. doi: 10.1016/j.ijmm.2015.08.023. Epub 2015 Aug 21.

PMID:
26341329
29.

Current prevalence of multidrug-resistant organisms in long-term care facilities in the Rhine-Main district, Germany, 2013.

Hogardt M, Proba P, Mischler D, Cuny C, Kempf VA, Heudorf U.

Euro Surveill. 2015 Jul 2;20(26). pii: 21171.

30.

Draft Genome Sequence of Pseudomonas aeruginosa Strain WS136, a Highly Cytotoxic ExoS-Positive Wound Isolate Recovered from Pyoderma Gangrenosum.

Arnold M, Wibberg D, Blom J, Schatschneider S, Winkler A, Kutter Y, Rückert C, Albersmeier A, Albaum S, Goesmann A, Zange S, Heesemann J, Pühler A, Hogardt M, Vorhölter FJ.

Genome Announc. 2015 Jul 2;3(4). pii: e00680-15. doi: 10.1128/genomeA.00680-15.

31.

Management of Microbiological Samples in a Confirmed Case of Ebola Virus Disease: Constraints and Limitations.

Hogardt M, Wolf T, Kann G, Brodt HR, Brandt C, Keppler OT, Wicker S, Zacharowski K, Gottschalk R, Becker S, Kempf VA.

J Clin Microbiol. 2015 Nov;53(11):3396-400. doi: 10.1128/JCM.01142-15. Epub 2015 Jun 24.

32.

Erratum to "Practical guidelines: lung transplantation in patients with cystic fibrosis".

Hirche TO, Knoop C, Hebestreit H, Shimmin D, Solé A, Elborn JS, Ellemunter H, Aurora P, Hogardt M, Wagner TO; ECORN-CF Study Group.

Pulm Med. 2015;2015:698460. doi: 10.1155/2015/698460. Epub 2015 Jan 28.

33.

Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection.

Hector A, Schäfer H, Pöschel S, Fischer A, Fritzsching B, Ralhan A, Carevic M, Öz H, Zundel S, Hogardt M, Bakele M, Rieber N, Riethmueller J, Graepler-Mainka U, Stahl M, Bender A, Frick JS, Mall M, Hartl D.

Am J Respir Crit Care Med. 2015 Apr 15;191(8):914-23. doi: 10.1164/rccm.201407-1381OC.

PMID:
25632992
34.

Zoonotic transmission of toxigenic Corynebacterium ulcerans strain, Germany, 2012.

Meinel DM, Konrad R, Berger A, König C, Schmidt-Wieland T, Hogardt M, Bischoff H, Ackermann N, Hörmansdorfer S, Krebs S, Blum H, Margos G, Sing A.

Emerg Infect Dis. 2015 Feb;21(2):356-8. doi: 10.3201/eid2102.141160.

35.

Draft Genome Sequence of Pseudomonas aeruginosa Strain WS394, a Multidrug-Resistant and Highly Cytotoxic Wound Isolate from Chronic Ulcus Cruris.

Vorhölter FJ, Arnold M, Wibberg D, Blom J, Winkler A, Viehoever P, Albersmeier A, Goesmann A, Zange S, Heesemann J, Pühler A, Hogardt M.

Genome Announc. 2014 Dec 18;2(6). pii: e01325-14. doi: 10.1128/genomeA.01325-14.

36.

A validation protocol and evaluation algorithms to determine compatibility of cell therapy product matrices in microbiological testing.

Klarmann D, Sireis W, Hogardt M, Kempf VA, Seifried E, Bonig H.

Cell Tissue Bank. 2015 Sep;16(3):311-8. doi: 10.1007/s10561-014-9474-5. Epub 2014 Sep 10.

PMID:
25204399
37.

Marker genes for the metabolic adaptation of Pseudomonas aeruginosa to the hypoxic cystic fibrosis lung environment.

Eichner A, Günther N, Arnold M, Schobert M, Heesemann J, Hogardt M.

Int J Med Microbiol. 2014 Nov;304(8):1050-61. doi: 10.1016/j.ijmm.2014.07.014. Epub 2014 Jul 28. Erratum in: Int J Med Microbiol. 2015 Sep;305(6):589.

PMID:
25130702
38.

Practical guidelines: lung transplantation in patients with cystic fibrosis.

Hirche TO, Knoop C, Hebestreit H, Shimmin D, Solé A, Elborn JS, Ellemunter H, Aurora P, Hogardt M, Wagner TO; ECORN-CF Study Group.

Pulm Med. 2014;2014:621342. doi: 10.1155/2014/621342. Epub 2014 Mar 30. Erratum in: Pulm Med. 2015;2015:698460.

39.

Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease.

Rieber N, Brand A, Hector A, Graepler-Mainka U, Ost M, Schäfer I, Wecker I, Neri D, Wirth A, Mays L, Zundel S, Fuchs J, Handgretinger R, Stern M, Hogardt M, Döring G, Riethmüller J, Kormann M, Hartl D.

J Immunol. 2013 Feb 1;190(3):1276-84. doi: 10.4049/jimmunol.1202144. Epub 2012 Dec 31.

40.

Indigestion after Digestive Disease Week (DDW): be aware of the "Golden Raspberry Award" at DDW and Cyclospora cayetanensis.

Brand S, Ochsenkühn T, Hogardt M.

Am J Gastroenterol. 2012 Dec;107(12):1927-9. doi: 10.1038/ajg.2012.311. No abstract available.

PMID:
23211863
41.

Sexually transmitted diphtheria.

Berger A, Lensing C, Konrad R, Huber I, Hogardt M, Sing A.

Sex Transm Infect. 2013 Mar;89(2):100-1. doi: 10.1136/sextrans-2011-050418. Epub 2012 May 23.

PMID:
22628666
42.

Pseudomonas aeruginosa outbreak in a pediatric oncology care unit caused by an errant water jet into contaminated siphons.

Schneider H, Geginat G, Hogardt M, Kramer A, Dürken M, Schroten H, Tenenbaum T.

Pediatr Infect Dis J. 2012 Jun;31(6):648-50. doi: 10.1097/INF.0b013e31824d1a11.

PMID:
22333699
43.

Microevolution of Pseudomonas aeruginosa to a chronic pathogen of the cystic fibrosis lung.

Hogardt M, Heesemann J.

Curr Top Microbiol Immunol. 2013;358:91-118. doi: 10.1007/82_2011_199. Review.

PMID:
22311171
44.

Staphylococcus aureus infection following nasal colonization: an approach to rapid risk stratification in a university healthcare system.

Seybold U, Schubert S, Bogner JR, Hogardt M.

J Hosp Infect. 2011 Dec;79(4):297-301. doi: 10.1016/j.jhin.2011.08.017. Epub 2011 Oct 21.

PMID:
22018814
45.

Toxigenic Corynebacterium ulcerans in woman and cat.

Berger A, Huber I, Merbecks SS, Ehrhard I, Konrad R, Hörmansdorfer S, Hogardt M, Sing A.

Emerg Infect Dis. 2011 Sep;17(9):1767-9. doi: 10.3201/eid1709.110391. No abstract available.

46.

Cutaneous infection by Mycobacterium haemophilum and kansasii in an IgA-deficient man.

Bekou V, Büchau A, Flaig MJ, Ruzicka T, Hogardt M.

BMC Dermatol. 2011 Jan 26;11:3. doi: 10.1186/1471-5945-11-3.

47.

Hospital-wide outbreak of Burkholderia contaminans caused by prefabricated moist washcloths.

Martin M, Christiansen B, Caspari G, Hogardt M, von Thomsen AJ, Ott E, Mattner F.

J Hosp Infect. 2011 Mar;77(3):267-70. doi: 10.1016/j.jhin.2010.10.004. Epub 2011 Jan 7.

PMID:
21216034
48.

Genotypic and phenotypic characterization of Pseudomonas aeruginosa isolates from urinary tract infections.

Tielen P, Narten M, Rosin N, Biegler I, Haddad I, Hogardt M, Neubauer R, Schobert M, Wiehlmann L, Jahn D.

Int J Med Microbiol. 2011 Apr;301(4):282-92. doi: 10.1016/j.ijmm.2010.10.005. Epub 2010 Dec 30.

PMID:
21193347
49.

Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry as a tool for rapid diagnosis of potentially toxigenic Corynebacterium species in the laboratory management of diphtheria-associated bacteria.

Konrad R, Berger A, Huber I, Boschert V, Hörmansdorfer S, Busch U, Hogardt M, Schubert S, Sing A.

Euro Surveill. 2010 Oct 28;15(43). pii: 19699. Erratum in: Euro Surveill. 2010;15(44)pii:19702.

50.

Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung.

Hogardt M, Heesemann J.

Int J Med Microbiol. 2010 Dec;300(8):557-62. doi: 10.1016/j.ijmm.2010.08.008. Epub 2010 Oct 12. Review.

PMID:
20943439

Supplemental Content

Loading ...
Support Center